JBC Ideal method for primary cell transfection

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M108088200 on September 25, 2001

J. Biol. Chem., Vol. 276, Issue 48, 44695-44703, November 30, 2001
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/48/44695    most recent
M108088200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ashton, A. C.
Right arrow Articles by Ushkaryov, Y. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ashton, A. C.
Right arrow Articles by Ushkaryov, Y. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

alpha -Latrotoxin, Acting via Two Ca2+-dependent Pathways, Triggers Exocytosis of Two Pools of Synaptic Vesicles*

Anthony C. AshtonDagger , Kirill E. VolynskiDagger , Vera G. LelianovaDagger , Elena V. OrlovaDagger §, Catherine Van Renterghem, Marco Canepari||, Michael Seagar, and Yuri A. UshkaryovDagger **

From the Dagger  Biochemistry Department, Imperial College, Exhibition Road, London SW7 2AY, United Kingdom, the  Laboratoire de Neurobiologie des Canaux Ioniques, INSERM U464, Faculté de Médecine Secteur Nord, Boulevard Pierre Dramard, F-139 16 Marseille Cedex 20, France, and the || Division of Neurophysiology, National Institute for Medical Research, London NW7 1AA, United Kingdom

Received for publication, August 22, 2001


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

alpha -Latrotoxin stimulates three types of [3H]gamma -aminobutyric acid and [14C]glutamate release from synaptosomes. The Ca2+-independent component (i) is insensitive to SNAP-25 cleavage or depletion of vesicle contents by bafilomycin A1 and represents transmitter efflux mediated by alpha -latrotoxin pores. Two other components of release are Ca2+-dependent and vesicular but rely on distinct mechanisms. The fast receptor-mediated pathway (ii) involves intracellular Ca2+ stores and acts upon sucrose-sensitive readily releasable vesicles; this mechanism is insensitive to inhibition of phosphatidylinositol 4-kinase (PI 4-kinase). The delayed pore-dependent exocytotic component (iii) is stimulated by Ca2+ entering through alpha -latrotoxin pores; it requires PI 4-kinase and occurs mainly from depot vesicles. Lanthanum perturbs alpha -latrotoxin pores and blocks the two pore-mediated components (i, iii) but not the receptor-mediated release (ii). alpha -Latrotoxin mutant (LTXN4C) cannot form pores and stimulates only the Ca2+-dependent receptor-mediated amino acid exocytosis (ii) (detectable biochemically and electrophysiologically). These findings explain experimental data obtained by different laboratories and implicate the toxin receptors in the regulation of the readily releasable pool of synaptic vesicles. Our results also suggest that, similar to noradrenergic vesicles, amino acid-containing vesicles at some point in their cycle require PI 4-kinase.


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

alpha -Latrotoxin (LTX)1 causes massive release of neurotransmitters (NTs) and is widely used to study exocytosis of synaptic and large dense-cored vesicles in neuronal and endocrine cells (1-4).

However, LTX has a complex mode of action. First, it binds to, and could activate, two unrelated neuronal receptors: neurexins (NRX) (5) and latrophilin (LPH) (6). Second, LTX forms large pores in the plasma membrane of receptor-expressing cells (7-10). These pores cause massive influx of Ca2+ with subsequent stimulation of exocytosis (1, 2, 11, 12), influx/efflux of other cations (7), efflux of NTs (8, 13, 14), and eventual disruption of cell morphology and function (15, 16). Therefore, to study any potential signaling mediated by the receptor(s), it is important to avoid toxin pore formation.

As we demonstrated recently, the toxin forms pores by assembling into cyclical tetramers, which insert into lipid bilayers (17). By using a LTX preparation that formed tetramers/pores only in the presence of Mg2+, we selectively studied the receptor-mediated LTX action in synaptosomes (8, 18, 19) and found that LTX-receptor interaction in the absence of pore formation causes norepinephrine (NE) exocytosis that requires both extracellular and stored Ca2+. On the other hand, release of amino acid (AA) transmitters, which mediate fast neurotransmission in the brain, could involve other mechanisms.

Therefore, the current work had two main objectives: to investigate the mechanism of LTX-induced release of L-glutamic acid (Glu) and gamma -aminobutyric acid (GABA) and to distinguish the pore- and receptor-dependent LTX actions. To avoid the toxin pore formation, we employed La3+ (which disrupts toxin tetramers) and a mutant LTX (which is unable to form such tetramers). The use of Botulinum neurotoxin type E (BoNT/E) and bafilomycin A1 (BAF) allowed us to identify true SV exocytosis. We demonstrate that, in the absence of Ca2+, LTX causes predominantly nonvesicular AA efflux. Toxin-evoked vesicular AA release is detectable biochemically only in the presence of Ca2+ and is based on two pharmacologically and temporally distinct mechanisms: (i) fast receptor-mediated phase that acts upon readily releasable SVs and (ii) delayed pore-mediated Ca2+ entry that stimulates depot vesicles. Our study confirms the differential regulation of the two vesicular pools and demonstrates the usefulness of mutant LTX for in-depth studies of AA release.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Materials-- alpha -Latrotoxin was purified from spider venom (19). Pure BoNT/E was a kind gift of Prof. J. O. Dolly. [2,3-3H]GABA, L-[U-14C]Glu, and 45Ca2+ were from Amersham Pharmacia Biotech. Thapsigargin (TG), BAPTA-AM, and U73122 were from Calbiochem; all other reagents were from Sigma.

Amino Acid Release from Synaptosomes-- Rat cerebrocortical synaptosomes, prepared as described (20), were suspended in physiological buffer (PB, containing, in mM: 125 NaCl, 5 KCl, 1 MgCl2, 10 glucose, 0.1 aminooxyacetic acid, and 25 HEPES, pH 7.4) supplemented with 2 mM CaCl2 and kept on ice until required. All buffers and suspensions were constantly oxygenated. In the short loading procedure, synaptosomes were incubated with 2-5 µCi/ml [3H]GABA or [14C]Glu at 37 °C for 5 min, washed, and stimulated 20 min later to reproduce conditions used by others (21). In the normal loading protocol, terminals were incubated for 5 min with [14C]Glu and for 60 min with [3H]GABA, washed, and incubated for 1 h at 37 °C in PB containing 0.1 mM EGTA (20).

During the post-loading incubation, some synaptosomes were treated with: 400 nM BoNT/E (2 h, eliminating 90% of SNAP-25) (20), 100 µM BAPTA-AM (1 h) (20), 1 µM BAF (1 h) (22), 10 µM U73122 (15 min), 10 µM TG (30 min, no less TG is required to cause specific effects in brain preparations) (23, 24), or 3 µM phenylarsine oxide (PAO, 15 min) (21). The latter three drugs were also included in subsequent buffers. Control samples were treated identically, using the drug-free solvents. Exposure to PAO did not exceed 25-35 min. In the short loading protocol, PAO was added 10 min before [14C]Glu, and this did not perturb NT uptake (21).

To evoke release, PB containing a stimulus (with Ca2+ or 0.1 mM EGTA) was added to synaptosomes at 24 °C; basal Ca2+-independent release was determined using stimulus-free PB/EGTA. For quick and thorough mixing and to prevent NT reuptake (20, 25), synaptosomes (10-25 µg of protein) were diluted by the stimulus 8-fold. Using high K+, maximal release was achieved at 25 mM K+. A23187 in dimethyl sulfoxide was diluted into Ca2+-containing PB 10 s before use. For comparison with superfusion studies where terminals were exposed to LTX for 1 min and release was evaluated over a longer period (21), some samples were stimulated for 1 min and then diluted 5-fold, resulting in subnanomolar LTX present during release measurements. Hypertonic stimulation was done by adding sucrose in PB/EGTA to a final concentration of 150 mM, which induced maximal vesicular release (identified using BAF); higher [sucrose] only intensified nonvesicular NT efflux.

To terminate Ca2+-dependent release, EGTA was added to 0.1 mM free concentration. LTX-evoked Ca2+-independent release was stopped by 0.1 mM LaCl3. Sucrose-stimulated samples were returned to isotonic conditions by adding low sodium PB. Prestimulation with high K+ was stopped by dilution with potassium-free PB. Samples were then centrifuged for 30 s, and the supernatant was recovered immediately. The radioactivity of the supernatant and pellet was determined by liquid scintillation counting. Phase 1 of LTX-evoked AA release was measured during the first 2 min for [14C]Glu and 1 min for [3H]GABA or over 5 min in the presence of La3+ for both AAs (both methods gave same results). Phase 2 was determined by subtracting phase 1 from the aggregate Ca2+-dependent release over 5 min (phases 1 and 2).

Production of Recombinant Toxins-- LTXWT and LTXN4C for baculovirus expression (26) were made similar to those described previously (27), except no poly-His tags were introduced (for better resemblance of native LTX). The recombinant toxins were purified from culture medium by affinity chromatography on an anti-LTX monoclonal antibody (kind gift of Prof. E. V. Grishin) attached to CNBr-activated Sepharose (Amersham Pharmacia Biotech). The toxins were eluted with 1 M MgCl2 and dialyzed against PB.

Electron Microscopy and Image Processing-- Cryo-electron microscopy (cryo-EM) and data analysis were carried out as described (17).

LTX Pore Formation-- LTX-stimulated influx of 45Ca2+ into synaptosomes was measured as described (8). For electrophysiological detection of LTX channels (9), baby hamster kidney (BHK) cells were transiently transfected with LPH (10) or an empty vector, mixed with a plasmid encoding green fluorescent protein (used to identify transfected cells). Whole-cell current recordings were performed 24 h later on isolated cells, using wide-tipped patch pipettes (1.5-3 megohms). Where indicated in figures, cells were perfused at 70 µl/min, using a local multichannel superfusion system. pClamp 6 software was used for experimental protocols and Biopatch for analysis. Whole-cell current traces are shown without leak subtraction, after low pass filtering.

Electrophysiological Recordings in Hippocampal Slices-- Immediately after extraction, 10-12-day-old rat brains were placed in ice-cold oxygenated artificial cerebrospinal fluid (also used for recordings) containing (in mM): 135 NaCl, 3 KCl, 2 CaCl2, 10 HEPES-Na, 2 MgSO4, 25 NaHCO3, 25 glucose, pH 7.3. Transverse vibratome-cut hippocampal slices (200 µm) were oxygenated for 1 h at 32 °C and then at room temperature until used. Slices were transferred to a perfused recording chamber mounted on an Axioskop 1FS microscope (Zeiss) equipped with a 40× Achroplan objective. The bath solution (32 °C) was oxygenated by a surface stream of hydrated O2. Whole-cell patch-clamp recordings, in voltage clamp conditions (-70 mV), were made from CA3 pyramidal neurons using an Axoclamp 2A amplifier (Axon Instruments), at a sampling frequency of 100 µs (12 bits). Patch pipettes (2-4 megohms) contained intracellular solution (in mM): 110 potassium gluconate, 10 KCl, 4 MgCl2, 50 HEPES, 4 Na2-ATP, 0.2 Na2-GTP, 10 creatine phosphate (pH 7.3). After 20 min in the whole-cell mode, perfusion was stopped, and 1 µM tetrodotoxin and 10 µM bicuculline were added to the bath to block action potentials and GABA-induced postsynaptic currents. Spontaneous Glu-induced miniature excitatory postsynaptic currents (mEPSCs) were recorded for 10-20 min before and after the addition of 0.5 nM LTXN4C. MiniAnalysis software (Synaptosoft) was used to analyze the traces.

Statistical Analysis-- The values in the figures are the means from several independent experiments done on multiple samples, with error bars indicating the S.E. Statistical significance of differences between control and test values (probability that the values are equal) was assessed by paired Student's t test (p values are shown near the respective points; NS, nonsignificant) or by the Kolmogorov-Smirnov two-sample test.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Loading Synaptosomes with Radiolabeled Transmitters-- To detect synaptosomal release of AAs, we chose a batch (versus superfusion) method, because it allows simultaneous and fast measurement of multiple samples and improves statistical evaluation of data. This assay yielded results comparable with fast superfusion (6 ml/min) (25).

When synaptosomes were incubated with [14C]Glu at 37 °C, a maximal radioactivity uptake was achieved in 5 min (data not shown). Labeled NT, taken up into the cytosol, requires some time to equilibrate with the vesicles. Therefore, in such short-loaded synaptosomes, vesicular release evoked by high K+ in a Ca2+-dependent manner was initially small but gradually increased upon further incubation at 37 °C and then remained stable for several hours (Fig. 1A). In contrast, a Ca2+-independent (probably cytosolic) component decreased with time (Fig. 1B). For [3H]GABA, the optimal loading/post-loading period was 120 min (data not shown). This optimized ("normal") loading protocol was used in most experiments below.


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 1.   Optimization of conditions for measuring AA release from nerve terminals. A and B, optimal time for loading terminals with radiolabeled AAs. Rat synaptosomes were incubated with [14C]Glu at 37 °C for 5 min, washed, and kept at 37 °C for indicated times prior to a final wash and a 1-min stimulation with 25 mM K+ ± 2.5 mM Ca2+. The Ca2+-dependent release (A) was determined by subtracting the release evoked in the absence of Ca2+ (B) from the total release in the presence of Ca2+. C and D, time courses and termination of Ca2+-dependent and -independent components of LTX-stimulated [14C]Glu release. Synaptosomes were loaded with [14C]Glu by the normal protocol. Control release (CON) was triggered by 3 nM LTX in the presence of 1.2 mM Ca2+ or 0.1 mM EGTA. Addition of 1.3 mM EGTA or 0.2 mM La3+, respectively, blocked any further release (arrows). For statistics, see "Experimental Procedures"; all results are from two independent experiments done in triplicate.

These results, in agreement with the earlier findings (28, 29), suggest that radiolabeled cytosolic NT first enters a limited number of vesicles but, with time, accumulates in a larger SV population.

LTX Evokes Three Distinct Types of AA Release-- In synaptosomes loaded by the normal procedure, LTX triggered both Ca2+-dependent and -independent AA release (Fig. 1, C and D). To accurately determine the amount and properties of these types of release, secretion had to be terminated rapidly and selectively prior to the separation step (see "Experimental Procedures"). Addition of EGTA instantly stopped the Ca2+-dependent effect of LTX (Fig. 1C) but could not prevent its Ca2+-independent action. We found, however, that 0.1 mM La3+ blocked the latter release immediately and completely (Fig. 1D) (3, 30). When mixed with LTX before synaptosomal intoxication, La3+ also prevented all evoked Ca2+-independent release (Fig. 2, A and B). Measured using this method, the Ca2+-independent AA secretion increased with LTX dose but always occurred at a constant rate.


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 2.   Three types of LTX-induced AA release. A and B, time courses of Ca2+-independent release of [14C]Glu and [3H]GABA. 3 nM LTX was added to loaded synaptosomes with 0.1 mM free La3+ (open circles) or without it (closed circles), in the presence of 0.1 mM EGTA. Release was measured as described under "Experimental Procedures" and the data plotted incrementally, i.e. as release occurring between consecutive 1-min intervals. C-F, time courses of Ca2+-dependent LTX-evoked release in the presence or absence of 0.1 mM La3+. Synaptosomes were loaded with radiolabeled AAs and stimulated by 3 nM LTX for [14C]Glu and 2 nM LTX for [3H]GABA, in the presence of various [Ca2+]e (right). Release was stopped at given times; the Ca2+-dependent component of LTX action was determined as in Fig. 1 and expressed incrementally. The two phases of this release (underlined below) were determined as outlined under "Experimental Procedures." G and H, the Ca2+ dependence of the two phases of LTX-evoked [14C]Glu and [3H]GABA release, respectively. The numbers of independent experiments done in triplicates were four (A, C, E, and G), five (B), three (D and F), and two (H).

In contrast, the Ca2+-dependent LTX-evoked release was not linear with time (Fig. 1C) and displayed two temporally separated phases (Fig. 2, C-F). Phase 1 was observed during the first 1-2 min after the addition of LTX and was the only Ca2+-dependent release detectable at low [Ca2+]e (Fig. 2, C and D). At higher [Ca2+]e, a delayed phase of secretion appeared (Fig. 2, E and F), although for [3H]GABA it partially overlapped with phase 1 (Fig. 2F). Ca2+e requirements of the two phases (Fig. 2, G and H) demonstrate that phase 1 reaches a maximum at 0.2-0.4 mM Ca2+, whereas a full expression of phase 2 requires more than 1 mM Ca2+. Most remarkably, La3+ abolished phase 2 of AA release but did not affect phase 1 (Fig. 2, C-F).

To compare the rates of the fast Ca2+-dependent and Ca2+-independent LTX actions, we used 5 nM LTX and determined a higher resolution time course. Under these conditions, phase 1 was complete in 30 s, with up to 2.9 ± 0.9% of total [14C]Glu being released within the first 15 s. Importantly, no Ca2+-independent release could be detected at these times, indicating that phase 1 of the Ca2+-dependent component is the fastest type of LTX-stimulated secretion.

La3+ Perturbs the Pore-dependent Release by Affecting LTX Tetramers-- La3+ blocks two types of LTX-evoked AA release: Ca2+-independent and delayed Ca2+-dependent. In noradrenergic terminals, these release types require the presence of LTX pores (19). Together, these findings suggest that La3+ inhibits AA release by affecting LTX pores. To examine any direct interaction of this cation with toxin pores, while excluding the involvement of nonreceptor neuronal proteins, we used BHK cells. In such cells transfected with LTX receptors, the toxin induces large pores (9). Addition of La3+ to the bath quickly inhibited conductance of these pores (Fig. 3A). This inhibitory effect was fully reversible upon washout, indicating that La3+ acts extracellularly and does not permanently damage LTX.


View larger version (39K):
[in this window]
[in a new window]
 
Fig. 3.   The mechanism of La3+-induced inhibition of LTX actions. A, LTX pores are blocked by La3+ directly and reversibly. BHK cells expressing LPH were voltage-clamped (-60 mV), and whole-cell currents recorded (inward currents downward). A local superfusion system was activated when indicated by bars. A manually applied dose of LaCl3 (10 µl, 1 mM, arrow) reversibly blocked the LTX-induced pores, which reappeared on washout. B, the number of LTX tetramers (4×) and dimers (2×) found in the absence or presence of 0.1 mM La3+. Vitrified samples were imaged by cryo-EM. Four micrographs were analyzed for each condition; the numbers of LTX dimers and tetramers found were expressed as percentages of the total number of individual molecular images. C, characteristic top views of LTX tetramers in the absence and presence of La3+. The numbers of independent experiments were five (A) and two (B and C); the number of individual images in C was ~800 for control and 84 for La3+-treated LTX.

LTX pores are formed by toxin tetramers inserting into the membrane (17), and La3+ is likely to block such pores by perturbing the tetramers. We studied the effect of La3+ on LTX structure by cryo-EM and found that only <10% of all molecules in a La3+-treated LTX sample were tetrameric, compared with 90-95% in control toxin (Fig. 3B). Furthermore, the few tetramers still found in 0.1 mM La3+ were grossly deformed; the shapes and relative positions of monomers became clearly altered, resulting in a nearly complete closure of the central pore (10-25 Å in control and <= 3 Å in the presence of La3+) (Fig. 3C).

Combined, these results indicate that La3+ inhibits some LTX actions by affecting the toxin pores and that both the Ca2+-independent and the delayed Ca2+-dependent components of LTX-evoked AA release rely on the presence of such pores. In contrast, the fast Ca2+-dependent phase does not require LTX pore formation.

Only Ca2+-dependent LTX-evoked Release Is Vesicular-- Because LTX pores are permeable to NTs (10), we checked whether any LTX-evoked release of radiolabeled AAs was caused by leakage through such pores. To identify vesicular secretion, we used two drugs: (i) BoNT/E, which cleaves SNAP 25, a SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) protein essential for exocytosis; and (ii) BAF, which blocks the vacuolar-type proton pump and prevents NT loading into SVs, thus decreasing measured exocytosis (22). Both reagents inhibited the Ca2+-dependent AA release stimulated by high K+ or Ca2+ ionophore, A23187 (Fig. 4, A-D). Similarly, these drugs blocked the Ca2+-dependent component of LTX action (Fig. 4, E and F). Moreover, both the slow and fast Ca2+-dependent components of LTX-evoked release were abolished (Fig. 4, I-L), confirming their exocytotic nature.


View larger version (33K):
[in this window]
[in a new window]
 
Fig. 4.   Only the Ca2+-dependent LTX-induced release is vesicular. A-F, intact SNAP-25 and vesicular AAs are required for Ca2+-dependent secretion triggered by various stimuli. G and H, neither the cleavage of SNAP-25 nor depletion of NT from vesicles perturbs the Ca2+-independent LTX-evoked release. I-L, both the fast and delayed phases of LTX-stimulated Ca2+-dependent release are exocytotic. Terminals were incubated at 37 °C with radiolabeled AAs for 10 min (the times of drug addition are indicated under "Experimental Procedures"), washed, and stimulated for 1 min by high K+ (A and B) or 5 µM A23187 (C and D), or for 5 min by 5 nM LTX (E-L), in the presence of 0.1 mM EGTA (G and H) or Ca2+ (2.5 mM in A and B; 1.2 mM in C-F and I-L). Release was determined as in Figs. 1 and 2 and expressed as percentage of control; control values were (percentages of the total AA content): A, 4.5; B, 3.9; C, 3.9; D, 5.5; E, 7.7; F, 7.3; G, 13.3; H, 11.8; I, 4.1; J, 4.0; K, 3.7; L, 6.9. All results are from two experiments done in triplicate.

In contrast, the Ca2+-independent LTX-evoked AA release was unperturbed in botulinized or BAF-treated terminals (Fig. 4, G and H), implying that the bulk of such release does not occur via conventional exocytosis. Because this type of release strictly depends on LTX pore formation (Figs. 2 and 3), we term it below "LTX-evoked pore-mediated efflux."

Ca2+-dependent Components of LTX-evoked Release Require Intracellular Ca2+ (Ca2+i)-- To further characterize the two types of Ca2+-dependent LTX-stimulated exocytosis, we asked whether Ca2+ acted as an extracellular co-factor for LTX or was required in the cytosol. Preloading synaptosomes with BAPTA substantially reduced the Ca2+-dependent AA release triggered by high K+ or by A23187 (Fig. 5, A-D), and inhibited both components of Ca2+-dependent LTX-evoked release (Fig. 4, E, F, H, and I). Thus, cytosolic Ca2+ is necessary for all Ca2+-dependent LTX actions.


View larger version (33K):
[in this window]
[in a new window]
 
Fig. 5.   The role of cytosolic Ca2+, internal Ca2+ stores, and PLC in the two phases of Ca2+-dependent LTX-evoked secretion. A and B, the Ca2+-dependent release stimulated over 1 min by 25 mM K+, 2.5 mM Ca2+. C and D, same for 5 µM A23187, 1.2 mM Ca2+. E-G, fast Ca2+-dependent component of LTX-stimulated release (phase 1). H-J, delayed phase of Ca2+-dependent LTX-evoked release (phase 2). K-M, Ca2+-independent LTX-evoked release measured in the presence of 0.1 mM EGTA over 5 min. Where indicated, drugs were added during the post-loading incubation of synaptosomes (see "Experimental Procedures"). 3 nM LTX was used for [14C]Glu and 2 nM for [3H]GABA release. Components of release were determined as in Figs. 1 and 2. The numbers of independent experiments done in quadruplicate were two (A-D), three (E, H, and K), and four (F, G, I, J, L, and M).

The Ca2+-independent LTX-evoked AA efflux has no Ca2+ requirement, and BAPTA-loaded terminals actually exhibited a larger amount of such release (Fig. 4, K and L).

Only the Fast Phase of Ca2+-dependent LTX-evoked Release Requires Ca2+ Stores and Phospholipase C (PLC)-- Cytosolic Ca2+ that participates in LTX actions may, at least in part, come from intracellular Ca2+ stores known to play an important role in LTX-triggered release of NE (8, 18, 19). Therefore, prior to stimulation with LTX, we depleted Ca2+ stores with TG. As a result, the fast phase of Ca2+-dependent LTX-evoked [14C]Glu release was greatly attenuated (Fig. 5G), whereas the delayed phase was not affected (Fig. 5J). Some intracellular Ca2+ stores can be mobilized by inositol trisphosphate, a product of PLC action. Indeed, inhibition of PLC by U73122 blocked the fast (Fig. 5G), but not the slow (Fig. 5J), phase of [14C]Glu release. Importantly, neither TG nor U73122 acted by simply causing depletion of vesicles, which could still be stimulated by sucrose (both AAs; data not shown). Thus, phase 1 may involve PLC-mediated mobilization of Ca2+i, whereas phase 2 is probably triggered directly by Ca2+ entering through the LTX pore.

As expected, the Ca2+-independent LTX pore-mediated release was unaffected by TG or U73122, indicating that this pathway does not involve Ca2+ stores or PLC (Fig. 5M).

Non-pore-forming LTX Mutant Evokes Fast Ca2+-dependent Exocytosis-- Thus, the fast phase of LTX-stimulated release did not involve pore formation but required mobilization of Ca2+i, a process that can be induced by receptor signaling (8, 27). However, a possibility remained that some LTX pores were not completely blocked by La3+. Therefore, to ascertain that phase 1 involves LTX receptor signaling, a toxin was needed that lacked any ability to form membrane pores. Coincidentally, an interesting LTX mutant (LTXN4C) had been described that bound to both LTX receptors and activated PLC but did not cause any Ca2+-independent secretion from synaptosomes (27).

Because LTX pores are responsible for Ca2+-independent release (Figs. 2 and 3), we hypothesized that LTXN4C was inactive in the absence of Ca2+ because it could not form pores. To test this hypothesis, we compared the pore-forming activities of LTXN4C and recombinant wild type toxin (LTXWT) by measuring influx of 45Ca2+ into synaptosomes. Addition of LTXWT (or native LTX; data not shown) caused 45Ca2+ accumulation in the terminals (Fig. 6A). In contrast, LTXN4C did not induce any Ca2+ influx (Fig. 6A). This result was confirmed by single-channel patch-clamp recordings in BHK cells expressing exogenous receptors. LTXN4C was incapable of forming pores in these cells (Fig. 6B), whereas LTXWT, added after the mutant, induced pores very efficiently (Fig. 6B), indicating that the inability to form pores was the feature of LTXN4C and not the cells.


View larger version (37K):
[in this window]
[in a new window]
 
Fig. 6.   Mutant LTXN4C fails to form pores but still evokes the Ca2+-dependent receptor-mediated exocytosis. A, LTXWT forms cation-permeable membrane pores, whereas LTXN4C does not. Synaptosomes were equilibrated with 2 mM 45Ca2+/Ca2+ and exposed to 3 nM LTXWT or LTXN4C; radioactive uptake was determined at different times. B, electrophysiological detection of channel formation by LTXWT. Whole-cell voltage-clamp current recordings were done on BHK cells expressing LPH (see Fig. 3). Main trace, 1 nM LTXN4C or LTXWT was added by superfusion as indicated by bars; hatched bars indicate wash periods. Inset, expanded main trace at the outset of LTXWT pore formation (two distinct channels are visible). C-H, components of NT release triggered by LTXWT and LTXN4C. Release from loaded synaptosomes was determined as in Fig. 2; both recombinant toxins were used at 2.5 nM for [3H]GABA and 4 nM for [14C]Glu. The Ca2+-independent efflux was measured over 5 min. I, LTXN4C causes a massive increase in the frequency of mEPSCs in rat hippocampal slices. Glu-mediated mEPSCs were recorded from hippocampal sections in the presence of 2 mM Ca2+ before or 1 min after the addition of 0.5 nM LTXN4C. J, cumulative probability distributions of mEPSC amplitudes, demonstrating that LTXN4C does not change the amplitude of mini-events. K, cumulative probability distributions of inter-event intervals, showing that LTXN4C dramatically shortens the intervals between mEPSCs. The data in A are from a representative experiment done in triplicate; other data are from sextuplet determinations in two (C, E, G) or one (D, F, and H) independent experiments (three preparations of recombinant toxins); B and I are representative traces (n = 5); J, Kolmogorov-Smirnov's two-tailed p > 0.5, n = 502 events for both samples; K, p < 0.00001, n = 500 intervals.

We then compared the actions of both recombinant toxins on AA release. LTXWT mimicked the native toxin and triggered all three components of release in synaptosomes (Fig. 6, C-H). In contrast, LTXN4C failed to induce both the delayed phase of Ca2+-dependent secretion and the Ca2+-independent pore-mediated efflux (Fig. 6, E-H). Strikingly, the mutant was equipotent with LTXWT in stimulating the fast phase of Ca2+-dependent AA exocytosis (Fig. 6, C and D). Patch-clamp recordings in CA3 neurons of rat hippocampal slices unequivocally demonstrated that, in the presence of Ca2+, LTXN4C causes a strong increase in the frequency of Glu-mediated asynchronous miniature events without altering their amplitudes (Fig. 6, I-K).

Our data indicate that LTXN4C is capable of triggering AA exocytosis (phase 1) without forming pores but by interacting with the toxin receptor(s).

The Delayed Ca2+-dependent LTX-evoked Release Requires Active PI 4-Kinase-- Because the two Ca2+-dependent phases had different pharmacological properties and time courses, they could involve different SV pools. Some NE-containing vesicles require active PI 4-kinase, and Ca2+-dependent LTX-evoked NE release is sensitive to an inhibitor of this enzyme, PAO (19, 21, 31). If AAs are released via a similar mechanism, their secretion must also be perturbed by PAO.

When testing this drug, we found that it considerably inhibited Ca2+-dependent [14C]Glu release evoked by high K+ or A23187 (Fig. 7, A and B). As reported previously (21), PAO had no effect on the Ca2+-independent release triggered by sucrose (Fig. 7C) or LTX (Fig. 7, H and I).


View larger version (34K):
[in this window]
[in a new window]
 
Fig. 7.   The two Ca2+-dependent phases of LTX-induced exocytosis occur from vesicular pools with different PI 4-kinase requirements and rates of AA uptake. A and B, Ca2+-dependent [14C]Glu release evoked over 1 min by 25 mM K+, 2.5 mM Ca2+ or 5 µM A23187, 1.2 mM Ca2+. C, [14C]Glu release evoked by 150 mM sucrose over 90 s in 0.1 mM EGTA. D-G, the Ca2+-dependent components of LTX-evoked [14C]Glu release measured as in Fig. 2 in the absence or presence of PAO or TG. H and I, Ca2+-independent LTX-stimulated [14C]Glu efflux over 5 min. Synaptosomes were loaded with radiolabeled AAs using normal (A-D, F, and H) or short (E, G, and I) protocols (outlined under "Experimental Procedures"). In the normal protocol, 3 µM PAO was added for the last 15 min of the post-loading incubation. In the short procedure, synaptosomes were incubated at 37 °C with TG (10 µM) for 25 min or with PAO (3 µM) for 10 min prior to the addition of [14C]Glu for 5 min, washed, and release was measured 20 min later. 3 nM LTX was used for [14C]Glu. Similar results were obtained with [3H]GABA. The results are from quadruplicate to sextuplet determinations; the numbers of independent experiments were four (A-D, F, and H) and two (E, G, and I).

However, when comparing the sensitivities to PAO of the two Ca2+-dependent phases of LTX-evoked AA release, we observed an interesting effect; surprisingly, the fast phase was unaltered (Fig. 7, D and E), whereas phase 2 was blocked completely (Fig. 7, F and G), indicating that these types of Ca2+-dependent release occur from vesicular pools with different sensitivities to PAO.

The Fast Ca2+-dependent LTX-evoked Release Occurs from a Fast-loading Pool of Vesicles-- Our results employing PAO agreed with previous findings for endogenous Glu secretion (31), whereas some authors did not observe any PAO-sensitive release of radiolabeled AAs (21). We noted, however, that the latter group had labeled synaptosomes for only 5 min, while our normal protocol required long post-loading periods (Fig. 1). We speculated that the length of loading might differentiate between vesicular pools with fast and slow loading kinetics. Therefore, we tested the effect of LTX on the "short-loaded" synaptosomes. Interestingly, short loading did not affect significantly phase 1 but abolished phase 2 of Ca2+-dependent LTX-evoked AA exocytosis (Fig. 7, D-G). Evidently, the latter phase occurs from a distinct SV pool that slowly accumulates radioactive AAs from the cytosol. The Ca2+-independent LTX pore-mediated AA efflux was similar in terminals loaded by either procedure (Fig. 7, H and I), further demonstrating that the Ca2+-dependent and -independent types of release occur from different NT pools.

We then tested whether the SV pool involved in the fast Ca2+-dependent LTX action retained its pharmacological features in such short-loaded terminals. As after the normal loading procedure, PAO still did not affect the fast Ca2+-dependent LTX exocytosis, whereas TG greatly attenuated it (Fig. 7E). As expected, the slow Ca2+-dependent component remained nonexistent (Fig. 7G), and neither drug affected the Ca2+-independent LTX pore-mediated Glu efflux (Fig. 7I). The same results were obtained in similar experiments with GABA (data not shown).

These findings indicate that the fast Ca2+-dependent LTX-evoked exocytosis occurs from a fast-loading vesicular pool that may require intact Ca2+ stores but not PI 4-kinase.

The Fast Phase of LTX-evoked Release Occurs from Sucrose- and Depolarization-sensitive Vesicles-- Being PAO-insensitive, phase 1 of Ca2+-dependent LTX exocytosis must occur from SVs that have already undergone PI 4-kinase-dependent priming. These vesicles may belong to the readily releasable pool (RRP) distinguished by its sensitivity to sucrose (32, 33). We found that 150 mM sucrose stimulated Ca2+-independent [14C]Glu release from synaptosomes (~9% of total AA content; e.g. Fig. 7C, control); this secretion was largely vesicular because pretreatment of terminals with BAF decreased it by 65 ±15%. Interestingly, the amount of AAs released by sucrose did not depend on the loading time or the length of stimulation (3-90 s; data not shown). However, the length of such stimulation had a profound effect on the efficacy of a second stimulus applied within 4 min (see Fig. 8, top panel, for experimental design): terminals stimulated first for 3 s produced the same release as untreated synaptosomes when challenged with sucrose for a second time (Fig. 8, A and B). In contrast, a prolonged (90 s) first stimulation strongly inhibited further sucrose-induced release (Fig. 8, A and B). Sensitivity to hypertonic solutions recovered slowly after 4 min.


View larger version (33K):
[in this window]
[in a new window]
 
Fig. 8.   Prestimulation of terminals with sucrose or high K+ perturb only the fast Ca2+-dependent LTX-evoked exocytosis. Top, the scheme of experiment. Synaptosomes were loaded with [14C]Glu or [3H]GABA using the normal (A and C-F) or short (B and G-N) loading protocol. The terminals were stimulated first (as shown below the graphs) for 3-90 s with 150 mM sucrose, 0.1 mM EGTA (SUC), for 5 min with 2 nM LTXN4C, 2.5 mM Ca2+ (N4C), or for 1 min with 25 mM K+, 2.5 mM Ca2+ (K+) and washed. The second stimulus (indicated above the graphs: 150 mM sucrose, 0.1 mM EGTA for 30 s or 2 nM LTX, 2.5 mM Ca2+ or 0.1 mM EGTA for 5 min) was applied 4 min later. A and B, effect of a variable length first hypertonic stimulation on subsequent sucrose-triggered release of [14C]Glu in terminals loaded by the normal or short procedure (as indicated). C-E and G-I, effect of a 90-s first stimulation with sucrose on the various types of [14C]Glu release evoked by LTX. F and J, effect of prestimulation with LTXN4C on subsequent sucrose-stimulated [14C]Glu release. K-N, effect of predepolarization with high K+ on subsequent LTX- or sucrose-evoked secretion. The results are from three independent experiments done in sextuplet.

This temporary depression of the RRP, similar to that observed previously (34-36), allowed us to test whether sucrose and Ca2+-dependent LTX mechanisms acted on the same SV pool. We found that a 90-s prestimulation with sucrose drastically reduced the subsequent Ca2+-dependent LTX phase 1 of [14C]Glu exocytosis (measured with or without La3+), whereas phase 2 remained unperturbed (Fig. 8, C and D). In a reverse experiment, to avoid irreversible pore formation by native LTX, we used LTXN4C (in the presence of Ca2+). The mutant strongly inhibited subsequent Ca2+-independent release triggered by sucrose (Fig. 8F). Sucrose and LTXN4C also reciprocally perturbed each other's action in the short-loaded synaptosomes, in which only the fast-loading vesicles contained [14C]Glu (Fig. 8, G, H, and J). Very similar data were obtained with [3H]GABA (data not shown). Combined, these results strongly suggest that sucrose and the fast LTX mechanism act on the same vesicular pool.

Interestingly, predepolarization of synaptosomes with high K+ inhibited the stimulation of this pool by LTX or sucrose (Fig. 8, K and N). In contrast, pretreatment with sucrose or high K+ had no effect on either the slow Ca2+-dependent (Fig. 8, D, H, and L) or the Ca2+-independent (Fig. 8, E, I, and M) LTX-evoked AA release, indicating that these types of release do not involve the RRP.

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Pore-dependent and -independent LTX Actions-- Of the two modes of LTX action (pore formation and receptor stimulation), the former is likely to cause the strongest effect. Indeed, large LTX pores (10-25 Å) (17), permeable to cations and NTs (7, 8, 13, 14), must perturb membrane potential, energy level, and cation balance in excitable cells (7, 13, 37) and cause cell/terminal death2 (15, 16). Nevertheless, many studies have concluded that LTX interaction with its receptor(s) can facilitate exocytosis (2, 4, 38, 39). Obviously, more reliable results can be obtained if pore formation is precluded. This has been achieved here by blocking LTX pores with La3+ and by using LTXN4C, which cannot form pores.

Trivalent cations can block LTX-evoked release, and this rapid, extracellular, and reversible inhibitory action (Figs. 1D and 3A) has been always attributed to the blockade of LTX pores (3, 7, 30). We have now revealed the molecular mechanism of this inhibition; La3+, likely residing in the pore center, induces conformational changes in LTX tetramers/pores, leading to the closure of the central channel and tetramer dissociation (Fig. 3, B and C). As a result, this cation selectively inhibits such AA release that depends on LTX pores: (i) exocytosis evoked by Ca2+ entry (Fig. 2, E and F) and (ii) nonvesicular efflux of cytosolic AAs (Fig. 2, A and B). In contrast, LTX binding to the receptors persists in 0.1 mM La3+ (27, 30) and could lead to receptor activation. Consistent with this idea and in agreement with the earlier findings (2, 40), some LTX actions are not blocked by La3+ (Fig. 2, C-F).

To avoid any direct effect of La3+ on synaptosomal secretion, we employed the LTX mutant. LTXN4C has ideal qualities; it binds to LPH and NRX and stimulates hydrolysis of phosphoinositides (27), but does not form pores (Fig. 6, A and B) or trigger Ca2+-independent NT release (27) (Fig. 6, G and H). We have now demonstrated3 that LTXN4C does not form pores because it cannot tetramerize. Consistent with that, LTXN4C fails to stimulate those events that require pore formation (Fig. 6, E-H) but causes receptor-mediated secretion (Fig. 6, C, D, and I).

Three Types of LTX-stimulated Release-- We have identified here at least three components of LTX action in synaptosomes: one Ca2+-independent and two Ca2+-dependent pathways (Fig. 2). These release types have very different properties and principal mechanisms and require a systematic analysis (as detailed below).

Ca2+-independent LTX-evoked Release-- Electrophysiologically detected quantal secretion caused by LTX in the absence of Ca2+ is weaker than the Ca2+-dependent exocytosis (2, 11, 12). In synaptosomes, however, the Ca2+-independent LTX action is inconsistently strong (27) and must (at least in part) come from the cytosol. Indeed, the cytosol contains >80% of endogenous synaptic AAs (37) that are used to refill SVs (41); in short-loaded synaptosomes, the radiolabeled cytosolic pool is even larger (see Fig. 1, A and B). Furthermore, the Ca2+-independent LTX-evoked release of several transmitters (NE, Glu, and GABA) biochemically measured in synaptosomes is insensitive to inhibitors of exocytosis: (i) clostridial neurotoxins (8) (Fig. 4), (ii) BAF (Fig. 4), or (iii) hypertonic or hyperkalemic overstimulation (Fig. 8). Together, these results indicate that the Ca2+-independent LTX effect in synaptosomes is largely nonvesicular. Being strictly dependent on the NT-permeable LTX pores, Ca2+-independent AA release is likely to represent leakage through such pores.

This seems to contradict electrophysiological recordings in tissue preparations clearly demonstrating vesicular release triggered by LTX in "zero" Ca2+ (e.g. Ref. 1). However, unlike release observed in synaptosomes, this secretion is blocked by clostridial toxins (2). In addition, Ca2+-independent quantal release evoked by LTX is 500-1000 times lower than that induced by sucrose (2). Therefore, although sucrose-stimulated secretion is detectable biochemically (~8-10% of the total synaptosomal pool; Figs. 7C and 8 (A and B)), the Ca2+-independent LTX-evoked exocytosis (~0.02%) is below the detection limit of radioassay.

Two Phases of Ca2+-dependent LTX Action-- In our experiments, the aggregate Ca2+-dependent LTX-stimulated release over 5 min constitutes (percentage of total content) 10.3 ± 2.0 for Glu and 11.8 ± 1.9 for GABA, which is compatible with the maximal amount of endogenous Glu that could be released from synaptosomes in a Ca2+-dependent fashion (8-16%) (29, 42). As verified by BoNT and BAF treatment (Fig. 4), the Ca2+-dependent components of LTX-triggered release are vesicular.

Our findings corroborate and extend the previously published data (21, 27, 43). (i) In addition to the Ca2+-independent AA release seen by these authors, we have now detected the Ca2+-dependent component, always observed electrophysiologically; (ii) having confirmed that LTXN4C is inactive in the absence of Ca2+, we have also found that it causes Ca2+-dependent exocytosis; (iii) having explained how La3+ inhibits the Ca2+-independent release (27), we have now demonstrated that the cation does not block the fast Ca2+-dependent action (as reported previously (40)). Several factors have allowed us to observe the Ca2+-dependent LTX actions. (i) Long loading of synaptosomes labeled the depot vesicles and revealed phase 2 (Figs. 2 (E-H) and 7F); (ii) instantaneous termination of release allowed us to detect the fast phase 1 of LTX action, usually lost with slow superfusion (<1 ml/min) (25); (iii) avoiding prestimulation of synaptosomes with high K+ before adding LTX preserved phase 1 (Fig. 8K).

Remarkably, we have also been able to divide the Ca2+-dependent LTX-evoked exocytosis into two temporally distinct phases. These phases have different pharmacological characteristics and, consequently, different underlying mechanisms. Phase 1 (i) is complete within 30-60 s after the addition of LTX (Fig. 2, C-F), (ii) requires <0.4 mM Ca2+e (Fig. 2, G and H), (iii) is independent of the toxin pore (not blocked by La3+), (iv) depends on internal Ca2+ stores and active PLC (Fig. 5G), and (v) is stimulated by LTXN4C (Fig. 6, C and D). Phase 2 (i) is delayed, producing detectable release only 2-4 min after LTX addition (Fig. 2, E and F), (ii) requires >1 mM Ca2+e, (iii) is sensitive to La3+, (iv) is insensitive to disruption of Ca2+ stores and inhibition of PLC (Fig. 5J), and (v) is not evoked by LTXN4C (Fig. 6, E and F). Phase 1, therefore, does not involve LTX pore formation, whereas phase 2 is probably caused by pore-mediated Ca2+ accumulation in the cytosol (Fig. 6A).

An important question arises about the nature of the fast phase. Is it evoked by toxin's partial internalization and direct activation of some exocytotic proteins (44) or is it mediated by the receptor(s)? The former hypothesis seems to be unlikely because (i) toxin internalization cannot be faster than pore formation and (ii) the mutant toxin, which is unable to internalize (44), still stimulates this phase of release upon binding to the receptors (Fig. 6). Therefore, this release must involve some receptor-transduced signaling.

Receptor-mediated Exocytosis-- What could be the mechanism of LTX receptor-mediated Ca2+-dependent AA release? As with the Ca2+-dependent release of NE (8), this component is sensitive to TG and U73122 (Figs. 5G and 7E), implicating internal Ca2+ stores and PLC. Activation of PLC by either LTXWT or LTXN4C (27) has features remarkably similar to those of the fast phase of AA release (Fig. 6, C and D): both require receptor binding and the presence of Ca2+e, and both are insensitive to La3+. It seems likely that inositol trisphosphate, a product of PLC action, could trigger mobilization of Ca2+ from intracellular stores. Whether the initial local increase in [Ca2+]i is sufficient to stimulate exocytosis (45) or whether it causes activation of store-operated Ca2+ channels and subsequent amplification of free [Ca2+]i remains the subject of future studies, as does the exact nature of these Ca2+ stores.

Which of the two LTX receptors may be involved in the two phases of AA release? Activation of PLC and mobilization of Ca2+i, which underlie LTX-evoked NE secretion (8) and the fast AA release, can be mediated by the heptahelical LPH coupled to Galpha q (18). On the other hand, both LPH and NRX (or even their nonsignaling mutants) can mediate the pore-dependent phase 2 (9, 10); this explains the results used to speculate that LTX acts without receptor activation (43). The future use of LTXN4C should help to determine the role of each receptor in LTX action.

Two Distinct SV Pools-- The most interesting distinction between the two phases of LTX-evoked Ca2+-dependent release is their differential sensitivity to PAO and loading time, implicating physiologically distinct vesicular pools.

When synaptosomes are loaded with radiolabeled AAs, the sucrose-sensitive RRP accumulates the label very quickly, in parallel with AA uptake into the cytosol. In contrast, the time necessary to load the second SV pool (Fig. 1A) appears surprisingly long (1-2 h) compared with ~20 s required for recovery of vesicles after stimulation (46). However, without stimulation, the endogenous NT present in some vesicles must prevent their loading with labeled cytosolic AAs. Thus, if a vesicular pool is emptied infrequently, it will be labeled only after a considerable delay. This consideration justifies our loading paradigm and supports the idea that the slow-loading SVs belong to the resting (depot) pool.

If synaptosomes are treated with PAO (inhibitor of PI 4-kinase, which participates in priming of vesicles for release) (31) and then loaded with radiolabeled AAs, release will be detected only from those vesicles that have passed the priming step prior to drug addition. Such SVs can be specifically released by sucrose (Fig. 7C), which only stimulates the RRP (32, 33), and by LTX (fast Ca2+-dependent phase, Fig. 7, D and E). We demonstrate that these two types of release occur from a common SV pool (Fig. 8, C, F, G, and J). Thus, the fast-loading vesicles insensitive to PAO must belong to the RRP. The size of this pool determined here is 6-8% of the total radioactive AA content, and this probably includes both the morphologically docked and near-membrane SVs (47).

On the other hand, Ca2+-dependent AA release induced by the delayed (pore-mediated) LTX action, by high K+/Ca2+, or by A23187 is sensitive to PAO (Fig. 7, A, B, and F), suggesting that it occurs from SVs that still need priming by PI 4-kinase. However, such release is absent in short-loaded synaptosomes (Figs. 1A and 7G), implying that: (i) the PAO-sensitive vesicles do not accumulate radiolabeled AAs during a short loading, and (ii) LTX pore acts on an SV pool distinct from the RRP. Because this pool contains unprimed and slow-loading SVs, it probably represents the depot pool.

The two SV pools are differentially regulated by the two Ca2+-dependent LTX mechanisms. The receptor-mediated pathway triggers rapid fusion of the RRP (probably by increasing local [Ca2+]i) but does not induce fusion of the depot vesicles. The latter may require sufficient Ca2+ entering via LTX pores (Fig. 6A). In gonadotrophs too, Ca2+ release from stores causes fast exocytosis, whereas a universal rise in [Ca2+]i induces only a slow granule fusion (45).

Can the depot vesicles be released separately, or do they become readily releasable prior to exocytosis? After repeated 4-s applications of hypertonic solutions or high frequency electrical stimulation, the RRP is depressed for 3-4 min (36). Similarly, in our experiments, once the RRP is released by a 90-s treatment with sucrose or by LTXN4C, replacement vesicles sensitive to these stimuli are not immediately available (Fig. 8, A-C, F, G, and J). Importantly, in such overstimulated synaptosomes, the LTX pore can still induce delayed Ca2+-dependent release (e.g. Fig. 8D) of vesicles that are sensitive to PAO but not to sucrose, indicating that the depot vesicles can be released independently, without necessarily becoming readily releasable.

Conclusions-- Our results indicate that LTX can be successfully used only when carefully separating out its diverse actions. We demonstrate that LTXN4C is a very useful probe for elucidating the receptor-mediated actions. An important implication of our findings is that the readily releasable vesicles can be selectively regulated via the LTX receptors; the mechanism of this regulation can now be studied using the mutant toxin.

    ACKNOWLEDGEMENTS

We thank Oliver Dolly for the gift of BoNT/E and Eugene Grishin for the anti-LTX monoclonal antibody.

    FOOTNOTES

* This work was supported by a Wellcome Trust senior European research fellowship (to Y. A. U.) and by grants from the CNRS (to C. V. R. and M. S.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Present address: Dept. of Crystallography, Birkbeck College, London WC1E 7HX, United Kingdom.

** To whom correspondence should be addressed. Tel.: 44-20-594-5237; Fax: 44-20-594-5207; E-mail: y.ushkaryov@ic.ac.uk.

Published, JBC Papers in Press, September 25, 2001, DOI 10.1074/jbc.M108088200

2 K. E. Volynski and Y. A. Ushkaryov, unpublished observations.

3 K. E. Volynski, D. Thomson, E. V. Orlove, C. Manser, A. C. Ashton, R. R. Ribchester, and Y. A. Ushkaryov, manuscript in preparation.

    ABBREVIATIONS

The abbreviations used are: LTX, alpha -latrotoxin; AA, amino acid(s); BAF, bafilomycin A1; BAPTA, 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid; BHK, baby hamster kidney; BoNT, Botulinum neurotoxin; cryo-EM, cryo-electron microscopy; GABA, gamma -aminobutyric acid; Glu, L-glutamic acid; LPH, latrophilin; mEPSC, miniature excitatory postsynaptic currents; NE, norepinephrine; NRX, neurexin; NT, neurotransmitter; PAO, phenylarsine oxide; PB, physiological buffer; PLC, phospholipase C; RRP, readily releasable pool; SV, synaptic vesicle; TG, thapsigargin.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Ceccarelli, B., and Hurlbut, W. P. (1980) J. Cell Biol. 87, 297-303
2. Capogna, M., Gahwiler, B. H., and Thompson, S. M. (1996) J. Neurophysiol. 76, 3149-3158
3. Rosenthal, L., Zacchetti, D., Madeddu, L., and Meldolesi, J. (1990) Mol. Pharmacol. 38, 917-923
4. Liu, J., and Misler, S. (1998) J. Neurosci. 18, 6113-6125
5. Ushkaryov, Y. A., Petrenko, A. G., Geppert, M., and Sudhof, T. C. (1992) Science 257, 50-56
6. Lelianova, V. G., Davletov, B. A., Sterling, A., Rahman, M. A., Grishin, E. V., Totty, N. F., and Ushkaryov, Y. A. (1997) J. Biol. Chem. 272, 21504-21508
7. Hurlbut, W. P., Chieregatti, E., Valtorta, F., and Haimann, C. (1994) J. Membr. Biol. 138, 91-102
8. Davletov, B. A., Meunier, F. A., Ashton, A. C., Matsushita, H., Hirst, W. D., Lelianova, V. G., Wilkin, G. P., Dolly, J. O., and Ushkaryov, Y. A. (1998) EMBO J. 17, 3909-3920
9. Van Renterghem, C., Iborra, C., Martin-Moutot, N., Lelianova, V., Ushkaryov, Y., and Seagar, M. (2000) Eur. J. Neurosci. 12, 3953-3962
10. Volynski, K. V., Meunier, F. A., Lelianova, V. G., Dudina, E. E., Volkova, T. M., Rahman, M. A., Manser, C., Grishin, E. V., Dolly, J. O., Ashley, R. H., and Ushkaryov, Y. A. (2000) J. Biol. Chem. 275, 41175-41183
11. Fesce, R., Segal, J. R., Ceccarelli, B., and Hurlbut, W. P. (1986) J. Gen. Physiol. 88, 59-81
12. Auger, C., and Marty, A. (1997) Neuron 19, 139-150
13. McMahon, H. T., Rosenthal, L., Meldolesi, J., and Nicholls, D. G. (1990) J. Neurochem. 55, 2039-2047
14. Deri, Z., Bors, P., and Adam-Vizi, V. (1993) J. Neurochem. 60, 1065-1072
15. Okamoto, M., Longenecker, H. E., Jr., Riker, W. F., Jr., and Song, S. K. (1971) Science 172, 733-736
16. Watanabe, O., Torda, M., and Meldolesi, J. (1983) Neuroscience 10, 1011-1024
17. Orlova, E. V., Rahman, M. A., Gowen, B., Volynski, K. E., Ashton, A. C., Manser, C., van Heel, M., and Ushkaryov, Y. A. (2000) Nat. Struct. Biol. 7, 48-53
18. Rahman, M. A., Ashton, A. C., Meunier, F. A., Davletov, B. A., Dolly, J. O., and Ushkaryov, Y. A. (1999) Philos. Trans. R. Soc. Lond. B Biol. Sci. 354, 379-386
19. Ashton, A. C., Rahman, M. A., Volynski, K. E., Manser, C., Orlova, E. V., Matsushita, H., Davletov, B. A., van Heel, M., Grishin, E. V., and Ushkaryov, Y. A. (2000) Biochimie (Paris) 82, 453-468
20. Ashton, A. C., and Dolly, J. O. (2000) J. Neurochem. 74, 1979-1988
21. Khvotchev, M., and Sudhof, T. C. (1998) J. Biol. Chem. 273, 21451-21454
22. Zhou, Q., Petersen, C. C., and Nicoll, R. A. (2000) J. Physiol. (Lond.) 525, 195-206
23. Irving, A. J., and Collingridge, G. L. (1998) J. Physiol. (Lond.) 511, 747-759
24. Savic, N., and Sciancalepore, M. (1998) Eur. J. Neurosci. 10, 3379-3386
25. Verhage, M., Sandman, H., Mosselveld, F., van de Velde, M., Hengst, P. A., Lopes da Silva, F. H., and Ghijsen, W. E. (1992) J. Neurochem. 58, 1313-1320
26. Volynski, K. E., Nosyreva, E. D., Ushkaryov, Y. A., and Grishin, E. V. (1999) FEBS Lett. 442, 25-28
27. Ichtchenko, K., Khvotchev, M., Kiyatkin, N., Simpson, L., Sugita, S., and Sudhof, T. C. (1998) EMBO J. 17, 6188-6199
28. Sihra, T. S., and Nicholls, D. G. (1987) J. Neurochem. 49, 261-267
29. Wilkinson, R. J., and Nicholls, D. G. (1989) Neurochem. Int. 15, 191-197
30. Scheer, H. W. (1989) J. Neurochem. 52, 1590-1597
31. Wiedemann, C., Schafer, T., Burger, M. M., and Sihra, T. S. (1998) J. Neurosci. 18, 5594-5602
32. Rosenmund, C., and Stevens, C. F. (1996) Neuron 16, 1197-1207
33. Lonart, G., and Sudhof, T. C. (2000) J. Biol. Chem. 275, 27703-27707
34. Verhage, M., Lopes da Silva, F. H., and Ghijsen, W. E. (1991) Neuroscience 43, 59-66
35. Ashton, A. C., and Dolly, J. O. (1997) J. Neurochem. 68, 649-658
36. Stevens, C. F., and Wesseling, J. F. (1999) Neuron 24, 1017-1028
37. Nicholls, D. G. (1989) J. Neurochem. 52, 331-341
38. Bittner, M. A., Krasnoperov, V. G., Stuenkel, E. L., Petrenko, A. G., and Holz, R. W. (1998) J. Neurosci. 18, 2914-2922
39. Bittner, M. A., and Holz, R. W. (2000) J. Biol. Chem. 275, 25351-25357
40. Misler, S., and Falke, L. C. (1987) Am. J. Physiol. 253, C469-C476
41. Sudhof, T. C. (1995) Nature 375, 645-653
42. McMahon, H. T., and Nicholls, D. G. (1991) J. Neurochem. 56, 86-94
43. Sugita, S., Ichtchenko, K., Khvotchev, M., and Südhof, T. C. (1998) J. Biol. Chem. 273, 32715-32724
44. Khvotchev, M., and Sudhof, T. C. (2000) EMBO J. 19, 3250-3262
45. Tse, F. W., Tse, A., Hille, B., Horstmann, H., and Almers, W. (1997) Neuron 18, 121-132
46. Stevens, C. F., and Tsujimoto, T. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 846-849
47. Richards, D. A., Guatimosim, C., and Betz, W. J. (2000) Neuron 27, 551-559


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike